See other companies on Welcome to the Jungle
Deciphex
Preclinical pathology software
- 101-200 employees
- Healthcare
- B2B
- Artificial Intelligence
- Productivity
- Deep Tech
- Machine Learning
- SaaS
- MedTech
- Botanic, Dublin, D
Jump to section
Company mission
To enable users to facilitate digital peer review of non-clinical pathology studies.
Our take
Pathologists are the core of diagnostics, but face increasing pressure as diagnostic complexity increases and the number of pathologists is in decline. This systemic strain means turnaround times for diagnoses are longer, and the chance of diagnostic error is higher. Deciphex is looking to address this with a regulated non-clinical pathology platform.
Deciphex has institutional and headline support, has collaborated with AstraZeneca and Janssen, and participates in a research program with pharmaceutical company Charles River. Reports suggest the platform has seen impressive uptake in the preclinical sector, so in spite of being relatively young this specialist niche is in high demand.
This all means Deciphex is in a strong position to keep expanding out its suite of tools and platforms. Its latest round of funding will support expansion across the US, UK, EU, Canada, and Japan. The company is also looking to enhance its capabilities, strengthen existing partnerships and broaden the type of customer it serves.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Cutting Edge Technology Space
- Multi Cultural, Diverse Team
- Autonomy & Trust in Your Role
- A Commitment to Flexible Working Arrangements
- Continued Learning and Development Opportunities
- Social Events
- Competitive Annual Leave
Company values
- Supportive - We know working together will bring success
- Diverse - We value our differences, skills, and perspectives
- Challenging - We're confident, innovative, and forward-thinking, and we're always learning
- Innovative - We aim high and won’t let anything stand in our way of achieving our goals
Funding (last 2 of 11 rounds)
Jan 2025
$32.3m
SERIES C
Jan 2023
$4.3m
LATE VC
Total funding: $59.6m
Leadership
Donal O’Shea
(Chief Executive)Has experience founding three companies prior to Deciphex, and has senior management experience in Slidepath, Genetix, Leica Microsystems and Leica Biosystems.
Articles
Jobs (7)
Software Engineering
Product
Finance, Legal & Compliance